Concurrent cisplatin and radiotherapy in advanced head and neck cancer
- PMID: 23119951
- PMCID: PMC3451075
- DOI: 10.1007/BF02974612
Concurrent cisplatin and radiotherapy in advanced head and neck cancer
Abstract
Management of Head and Neck Cancers poses a challenge inspite of several advances because of poor success in terms of response rate, survival and reduced morbidity of the patients. In the present study 30 untreated histologically proven cases of head and neck cancers were subjected to weekly radiotherapy with adjuvant chemotherapy (cisplatin 30 mg/m(2) intravenously). This study group was compared with a group of 30 patients who were given only radiotherapy. Results have shown that combination of chemotherapy with radiotherapy gives a significantly better results in tumour as well as nodal response with minimal toxicities.
References
-
- Bruce Leipzig et al C P sensitization to RT of SCC s of the Head and Neck LJS Vol 146 Pg 462–485
-
- G Amborisini et al (Feb 1988)Comination of CP and Radiotherapy in advanced Head and Neck Cancer An update proceedings Second International Congress on Neoadjuvant Chemotherapy held in Paris 19 21
-
- J E Hamper III The management of Head and Neck Cancer
-
- John R Clark, Amon I Drey fuss. Role of CP in Treatment regimens for SCC of the Head and Neck. Sem in Oncal. 1991;18(1):34–48.
-
- Muhyi Al Sarraf, et al. Concurrent RT and CT with Cisplatin in inoperable SCC of the Head and Neck. An RTOG Study Cancer. 1987;59:259–265. - PubMed
LinkOut - more resources
Full Text Sources